This inventor holds 1 USPTO granted patent. Top assignee: Genmab B.v.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Andreas Hollenstein: Innovator in Polypeptide Variants
Introduction
Andreas Hollenstein is a notable inventor based in Utrecht, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptide variants. His work has implications for various applications in medicine and research.
Latest Patents
Hollenstein holds a patent titled "Polypeptide Variants and Uses Thereof." This patent showcases his innovative approach to modifying polypeptides for enhanced functionality. He has 1 patent to his name, reflecting his commitment to advancing scientific knowledge and technology.
Career Highlights
Andreas Hollenstein is currently employed at Genmab B.V., a leading biotechnology company known for its focus on developing differentiated antibody therapeutics for the treatment of cancer. His role at Genmab allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Throughout his career, Hollenstein has worked alongside talented colleagues, including Simone Oostindie and Frank Beurskens. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Andreas Hollenstein is a prominent figure in the biotechnology sector, with a focus on polypeptide variants. His contributions through patents and collaborations highlight his dedication to scientific advancement. His work continues to influence the landscape of medical research and development.